Clinical Trials Browser

Recurrence × Introns × Dermatologic × Clear all

NCT01622933 2017-08-31

Multiple Antigen-Engineered DC Vaccine for Melanoma

Phase 1 Completed

Melanoma, Neoplasm Metastasis, Recurrence